{"url_path":"/sec/ttrx/8-k/2026-06-03/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/2023016/0001213900-26-064405-index.html","accession_number":"0001213900-26-064405","cik":"0002023016","ticker":"TTRX","issuer_name":"Turn Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2023016/0001213900-26-064405-index.html","primary_entity_key":"0002023016","primary_entity_name":"Turn Therapeutics Inc."},"word_count":81,"has_tables":true,"body_markdown":"**Item 9.01\nFinancial Statements and Exhibits.**\n\n \n\n**(d) Exhibits**\n\n \n\n**Exhibit No.**\n \n**Description**\n\n99.1\n \n[Investor Presentation, dated June 3, 2026](ea029312801ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**TURN THERAPEUTICS INC.**\n\n \n \n\nDate: June 3, 2026\n \n\n \n \n\n \nBy:\n/s/ Bradley Burnam\n\n \nName:\nBradley Burnam\n\n \nTitle:\nChief Executive Officer\n\n \n\n2"}